Arterys Cardio DL vs HeartFlow Analysis
AI Verdict
Choose Arterys Cardio DL if…
Choose Arterys Cardio DL if your primary need is rapid, automated, and highly accurate quantitative analysis of cardiac MRI studies. This tool is ideal for clinicians requiring precise ventricle segmentations, 4D blood flow visualization, and quantitative delayed enhancement analysis to streamline cardiac MRI interpretation and improve diagnostic confidence.
View Arterys Cardio DL →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-powered solution for diagnosing and managing coronary artery disease from standard CT scans. This tool is particularly well-suited for assessing the functional significance of coronary stenoses via FFRct and characterizing plaque burden, offering a comprehensive and personalized approach to CAD evaluation.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Arterys Cardio DL | HeartFlow Analysis |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Arterys Cardio DLArterys Cardio DL explicitly highlights features that enhance usability, such as 'drastically reducing interpretation time' and 'rapid analysis (seconds vs. 30-60 minutes)' with 'editable automated contours'. This directly addresses the clinician's workflow efficiency and control.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis offers a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by providing AI-powered 3D models and Fractional Flow Reserve derived from CT (FFRct) analysis. This provides a significant clinical benefit by potentially reducing the need for invasive procedures while maintaining high diagnostic accuracy.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis provides clear transparency regarding its pricing model, noting a fee-for-service structure covered by Medicare and most U.S. commercial payers, with established Category I CPT codes and CMS payment rates. This offers a clear financial pathway and value proposition for healthcare providers.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Arterys Cardio DL's mention of 'vendor-agnostic compatibility' is a slight advantage for broader integration, but HeartFlow's commercial maturity and specified AWS deployment also indicate robust readiness.
Innovation
HeartFlow AnalysisHeartFlow Analysis's FFRct technology, which non-invasively derives functional information from standard CT scans using AI and Computational Fluid Dynamics, represents a groundbreaking innovation in cardiology. This significantly transforms the diagnostic pathway for coronary artery disease by offering a non-invasive alternative to traditional invasive FFR.
Support & Docs
HeartFlow AnalysisHeartFlow offers a comprehensive support ecosystem, including specialized assistance for billing and reimbursement, technology integration with PACS and EMR, educational tools, and peer-to-peer mentorship. This extensive support goes beyond basic technical assistance, facilitating successful adoption and ongoing use in a clinical setting.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Arterys Cardio DL | HeartFlow Analysis |
|---|---|---|
| Name | Arterys Cardio DL | HeartFlow Analysis |
| Company | ARTERYS | HeartFlow |
| Description | FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Primary Imaging Modality | Cardiac MRI | CT scans (Coronary CT Angiogram - CCTA) |
| Key Features | Automated ventricle segmentations for cardiac MRI; Deep learning algorithms for image analysis; Cloud-based platform; Vendor-agnostic compatibility; Rapid analysis (seconds vs. 30-60 minutes); Editable automated contours; 4D Flow post-processing for blood flow visualization and quantification; Quantitative Delayed Enhancement analysis. | AI-powered 3D modeling of coronary arteries; Fractional Flow Reserve derived from CT (FFRct) analysis; Plaque Analysis (quantification and characterization); Roadmapu2122 Analysis for CCTA reading; Non-invasive diagnostic assessment; Personalized patient insights; Computational Fluid Dynamics (CFD) for blood flow simulation; High diagnostic accuracy. |
Videos
Demos, reviews, and walkthroughs featuring Arterys Cardio DL and HeartFlow Analysis.